Overview

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of treatment of striae distensae using the combined modality of fractional laser and poly-L lactic acid (Sculptra).
Phase:
Early Phase 1
Details
Lead Sponsor:
Henry Ford Health System
Collaborators:
Galderma
Galderma R&D
Treatments:
Mannitol